{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T10:47:17Z","timestamp":1783248437645,"version":"3.54.6"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.cld.2018.03.011","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T23:34:50Z","timestamp":1530747290000},"page":"613-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Current Status of Liver Transplantation for Primary Biliary Cholangitis"],"prefix":"10.1016","volume":"22","author":[{"given":"Maria T.","family":"Aguilar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.cld.2018.03.011_bib1","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.cld.2018.03.011_bib2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.cld.2018.03.011_bib3","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cgh.2007.07.015","article-title":"Transplantation trends in primary biliary cirrhosis","volume":"5","author":"Lee","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2018.03.011_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2018.03.011_bib5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0168-8278(05)80139-4","article-title":"Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years","volume":"20","author":"Mahl","year":"1994","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2018.03.011_bib6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.510290301","article-title":"Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis","volume":"29","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.cld.2018.03.011_bib7","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMct074694","article-title":"Ursodeoxycholic acid for the treatment of primary biliary cirrhosis","volume":"357","author":"Lindor","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cld.2018.03.011_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(03)00192-2","article-title":"Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis","volume":"39","author":"Poupon","year":"2003","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2018.03.011_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2018.03.011_bib10","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2147\/TCRM.S113052","article-title":"New developments in the treatment of primary biliary cholangitis: role of obeticholic acid","volume":"13","author":"Jhaveri","year":"2017","journal-title":"Ther Clin Risk Manag"},{"issue":"7","key":"10.1016\/j.cld.2018.03.011_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A\u00a0placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2018.03.011_bib12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.23683","article-title":"The specificity of fatigue in primary biliary cirrhosis: evaluation of a large clinic practice","volume":"52","author":"Al-Harthy","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2018.03.011_bib13","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1053\/gast.2002.32993","article-title":"The true impact of fatigue in primary biliary cirrhosis: a population study","volume":"122","author":"Goldblatt","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2018.03.011_bib14","doi-asserted-by":"crossref","first-page":"295891","DOI":"10.1155\/2015\/295891","article-title":"Management of pruritus in chronic liver disease","volume":"2015","author":"Bhalerao","year":"2015","journal-title":"Dermatol Res Pract"},{"issue":"2","key":"10.1016\/j.cld.2018.03.011_bib15","first-page":"82","article-title":"Osteoporosis in primary biliary cirrhosis of the liver","volume":"9","author":"Raszeja-Wyszomirska","year":"2014","journal-title":"Prz Gastroenterol"},{"issue":"9081","key":"10.1016\/j.cld.2018.03.011_bib16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(97)05419-6","article-title":"Primary biliary cirrhosis","volume":"350","author":"Neuberger","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cld.2018.03.011_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2018.03.011_bib18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2018.03.011_bib19","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2018.03.011_bib20","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cld.2018.03.011_bib21","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","article-title":"Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis","volume":"105","author":"Kumagi","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2018.03.011_bib22","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","article-title":"Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome","volume":"55","author":"Corpechot","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2018.03.011_bib23","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","article-title":"Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy","volume":"149","author":"Lammers","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2018.03.011_bib24","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"issue":"26","key":"10.1016\/j.cld.2018.03.011_bib25","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM198906293202602","article-title":"Efficacy of liver transplantation in patients with primary biliary cirrhosis","volume":"320","author":"Markus","year":"1989","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cld.2018.03.011_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hep.510280106","article-title":"Optimal timing of liver transplantation for primary biliary cirrhosis","volume":"28","author":"Kim","year":"1998","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2018.03.011_bib27","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cgh.2007.02.031","article-title":"Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis","volume":"5","author":"Levy","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10003","key":"10.1016\/j.cld.2018.03.011_bib28","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.cld.2018.03.011_bib29","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s11605-010-1256-1","article-title":"Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases: an analysis of the UNOS database","volume":"14","author":"Kashyap","year":"2010","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.cld.2018.03.011_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cld.2007.04.008","article-title":"Current indications and contraindications for liver transplantation","volume":"11","author":"Ahmed","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2018.03.011_bib31","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2741\/3966","article-title":"Liver transplantation in chronic cholestatic conditions","volume":"17","author":"Milkiewicz","year":"2012","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"3","key":"10.1016\/j.cld.2018.03.011_bib32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2013.04.017","article-title":"The effect of liver transplantation on fatigue\u00a0in patients with primary biliary cirrhosis: a prospective study","volume":"59","author":"Carbone","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2018.03.011_bib33","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0168-8278(03)00143-0","article-title":"Osteoporosis in liver diseases and after liver transplantation","volume":"38","author":"Hay","year":"2003","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2018.03.011_bib34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/tri.12877","article-title":"Primary biliary cirrhosis has high wait-list mortality among patients listed for liver transplantation","volume":"30","author":"Singal","year":"2017","journal-title":"Transpl Int"},{"issue":"2","key":"10.1016\/j.cld.2018.03.011_bib35","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00535-013-0782-5","article-title":"Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system","volume":"49","author":"Genda","year":"2014","journal-title":"J\u00a0Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2018.03.011_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198201073060101","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation","volume":"306","author":"Neuberger","year":"1982","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cld.2018.03.011_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/jlts.2003.36392","article-title":"Liver transplantation for primary biliary cirrhosis: a long-term pathologic study","volume":"9","author":"Khettry","year":"2003","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2018.03.011_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin Transplant"},{"issue":"7","key":"10.1016\/j.cld.2018.03.011_bib39","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1053\/jlts.2001.26055","article-title":"Recurrent primary biliary cirrhosis","volume":"7","author":"Neuberger","year":"2001","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2018.03.011_bib40","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/jlts.2003.50096","article-title":"Recurrent primary biliary cirrhosis","volume":"9","author":"Neuberger","year":"2003","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2018.03.011_bib41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/lt.21960","article-title":"Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity","volume":"16","author":"Manousou","year":"2010","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2018.03.011_bib42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience","volume":"21","author":"Rowe","year":"2008","journal-title":"Transpl Int"},{"issue":"3","key":"10.1016\/j.cld.2018.03.011_bib43","first-page":"35","article-title":"Mayo risk score for primary biliary cirrhosis: a useful tool for the prediction of course after liver transplantation?","volume":"13","author":"Jacob","year":"2008","journal-title":"Ann Transplant"},{"issue":"10","key":"10.1016\/j.cld.2018.03.011_bib44","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/jlts.2003.50213","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history","volume":"9","author":"Sylvestre","year":"2003","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2018.03.011_bib45","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0168-8278(95)80033-6","article-title":"Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis","volume":"23","author":"Dubel","year":"1995","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2018.03.011_bib46","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.1840180617","article-title":"Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation","volume":"18","author":"Balan","year":"1993","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2018.03.011_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1665-2681(19)31659-X","article-title":"Anti-parietal cell autoantibodies (PCA) in primary\u00a0biliary cirrhosis: a putative marker for recurrence after orthotopic liver transplantation?","volume":"9","author":"Ciesek","year":"2010","journal-title":"Ann Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2018.03.011_bib48","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1600-6143.2010.03038.x","article-title":"Recurrent primary biliary cirrhosis after\u00a0liver transplantation","volume":"10","author":"Silveira","year":"2010","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.cld.2018.03.011_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2018.03.011_bib50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/lt.20856","article-title":"Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis","volume":"13","author":"Morioka","year":"2007","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2018.03.011_bib51","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.transproceed.2014.02.021","article-title":"Chronic immune-mediated reaction syndrome as the cause of late graft mortality in living-donor liver transplantation for primary biliary cirrhosis","volume":"46","author":"Harimoto","year":"2014","journal-title":"Transplant Proc"},{"issue":"11","key":"10.1016\/j.cld.2018.03.011_bib52","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.cld.2018.03.011_bib53","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/gene.2012.17","article-title":"Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis","volume":"13","author":"Invernizzi","year":"2012","journal-title":"Genes Immun"},{"issue":"7","key":"10.1016\/j.cld.2018.03.011_bib54","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/jlts.2001.25357","article-title":"Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up study","volume":"7","author":"Hashimoto","year":"2001","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2018.03.011_bib55","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.transproceed.2005.03.130","article-title":"Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival","volume":"37","author":"Jacob","year":"2005","journal-title":"Transplant Proc"},{"issue":"7","key":"10.1016\/j.cld.2018.03.011_bib56","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/jlts.2003.50132","article-title":"The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation","volume":"9","author":"Levitsky","year":"2003","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2018.03.011_bib57","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","article-title":"Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation","volume":"10","author":"Montano-Loza","year":"2010","journal-title":"Am J Transpl"},{"issue":"4","key":"10.1016\/j.cld.2018.03.011_bib58","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Neuberger","year":"2004","journal-title":"Liver Transpl"},{"issue":"12","key":"10.1016\/j.cld.2018.03.011_bib59","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.cld.2018.03.011_bib60","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/lt.20511","article-title":"Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant","volume":"11","author":"Guy","year":"2005","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2018.03.011_bib61","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jhep.2015.07.038","article-title":"Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence","volume":"63","author":"Bosch","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2018.03.011_bib62","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after\u00a0liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transpl"},{"issue":"6\u20137","key":"10.1016\/j.cld.2018.03.011_bib63","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.clinre.2011.02.007","article-title":"Liver transplantation in PBC and PSC: indications and disease recurrence","volume":"35","author":"Carbone","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118300369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118300369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T14:42:52Z","timestamp":1693752172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326118300369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1089326118300369"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2018.03.011","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Status of Liver Transplantation for Primary Biliary Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2018.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}